K'Lynne Johnson

Director at DMC Biotechnologies.

Raised on DMC Biotechnologies filings

$4.8M

of $10M offered across 1 Form D filing

Form D filings: 1
Teammates: 7
Last filing: Apr 23, 2025

Company

DMC Biotechnologies

Biotech · Boulder, CO

Specialty chemicals made by microbial fermentation

Specialty chemicals made by microbial fermentation

Investors: 9
Still open: $5.2M

Investors: 9
Sector: Biotech
HQ: Boulder, CO

DMC Biotechnologies filings

DMC Biotechnologies Form D filings
Filed	Security	Sold of offered	Filing
Apr 23, 2025	Equity	$4.8M/ $10M	Form D

EquityFiled Apr 23, 2025Form D
$4.8M/ $10M

Works with

Also named on DMC Biotechnologies filings

Jim FlattChief Executive Officer, Form D signerForm D signer Josh YelenExecutive Officer Rob van der MeijDirector Alastair CooperDirector Doug CameronDirector Josko BobanovicDirector Matthew LipscombDirector